Inhibition of phosphorylation of the colony-stimulating factor-1 receptor (c-Fms) tyrosine kinase in transfected cells by ABT-869 and other tyrosine kinase inhibitors.

Inhibition of phosphorylation of the colony-stimulating factor-1 receptor (c-Fms) tyrosine kinase in transfected cells by ABT-869 and other tyrosine kinase inhibitors.

Item
http://www.wikidata.org/entity/Q34519442
Osteosarcoma cell-intrinsic colony stimulating factor-1 receptor functions to promote tumor cell metastasis through JAG1 signalingTumor cells and tumor-associated macrophages: secreted proteins as potential targets for therapy.An open-label, phase 1 study evaluating safety, tolerability, and pharmacokinetics of linifanib (ABT-869) in Japanese patients with solid tumors.Spectrophotometric and molecular modelling studies on in vitro interaction of tyrosine kinase inhibitor linifanib with bovine serum albuminA review of the latest clinical compounds to inhibit VEGF in pathological angiogenesis.VEGF/VEGFR signalling as a target for inhibiting angiogenesis.Phase I clinical trial combining imatinib mesylate and IL-2 in refractory cancer patients: IL-2 interferes with the pharmacokinetics of imatinib mesylate.Tyrosine kinase inhibitors reverse type 1 diabetes in nonobese diabetic mice.ABT-869, a promising multi-targeted tyrosine kinase inhibitor: from bench to bedside.c-FMS inhibitors: a patent review.FMS Kinase Inhibitors: Current Status and Future Prospects.Review of angiogenesis in hepatocellular carcinoma.Simple, sensitive and rapid determination of linifanib (ABT-869), a novel tyrosine kinase inhibitor in rat plasma by UHPLC-MS/MS.Development of a protease-resistant reporter to quantify BCR-ABL activity in intact cells.Phase 2 trial of linifanib (ABT-869) in patients with unresectable or metastatic hepatocellular carcinoma.CSF-1R regulates non-small cell lung cancer cells dissemination through Wnt3a signaling.Clinical pharmacodynamic/exposure characterisation of the multikinase inhibitor ilorasertib (ABT-348) in a phase 1 dose-escalation trial.
P2860

Inhibition of phosphorylation of the colony-stimulating factor-1 receptor (c-Fms) tyrosine kinase in transfected cells by ABT-869 and other tyrosine kinase inhibitors.

Item
http://www.wikidata.org/entity/Q34519442
description
2006 nî lūn-bûn
@nan
2006 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
Inhibition of phosphorylation ...... er tyrosine kinase inhibitors.
@ast
Inhibition of phosphorylation ...... er tyrosine kinase inhibitors.
@en
Inhibition of phosphorylation of the colony-stimulating factor-1 receptor
@nl
type
label
Inhibition of phosphorylation ...... er tyrosine kinase inhibitors.
@ast
Inhibition of phosphorylation ...... er tyrosine kinase inhibitors.
@en
Inhibition of phosphorylation of the colony-stimulating factor-1 receptor
@nl
prefLabel
Inhibition of phosphorylation ...... er tyrosine kinase inhibitors.
@ast
Inhibition of phosphorylation ...... er tyrosine kinase inhibitors.
@en
Inhibition of phosphorylation of the colony-stimulating factor-1 receptor
@nl
P1433
P1476
P2093
P304
P31
P356
P433
P478
P577
P698
P921
P356
P1433
P1476
Inhibition of phosphorylation ...... er tyrosine kinase inhibitors.
@en
P2093
P304
P31
P356
10.1158/1535-7163.MCT-05-0359
P433
P478
P577
P698
P921